Anatoly Braylovsky
Internal Medicine · Wallingford, CTNPI 1023004124
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 220 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations.
Across 220 payments — averaging $14.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$432
- AstraZeneca$305
- Boehringer Ingelheim$257
- Pfizer$249
- Scilex Pharmaceuticals Inc.$242
- Amgen$201
- plus $1K from 26 others
What the payments were for
- Food & beverage$3,04498%
- Education$572%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 40 | $432 |
| AstraZeneca | 21 | $305 |
| Boehringer Ingelheim | 15 | $257 |
| Pfizer | 20 | $249 |
| Scilex Pharmaceuticals Inc. | 13 | $242 |
| Amgen | 10 | $201 |
| Merck | 14 | $182 |
| Collegium Pharmaceutical, Inc. | 20 | $168 |
| Lilly USA, LLC | 13 | $159 |
| Indivior Inc. | 6 | $100 |
| AbbVie(2 entities) | 5 | $86 |
| Amarin Pharma, Inc. | 5 | $81 |
| Orexo US, Inc. | 4 | $71 |
| Daiichi Sankyo Inc. | 4 | $68 |
| Insulet Corporation | 3 | $61 |
| Alkermes, Inc. | 3 | $56 |
| MDD US Operations, LLC | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Shire North American Group Inc | 2 | $35 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $32 |
| Kaleo, Inc. | 2 | $32 |
| Johnson & Johnson | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $30 |
| GSK | 1 | $20 |
| Ironwood Pharmaceuticals, Inc | 1 | $19 |
| Avanir Pharmaceuticals, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Seqirus USA Inc | 1 | $16 |
| Assertio Therapeutics, Inc. | 1 | $15 |
| Lupin Inc. | 1 | $14 |
| Oxford Immunotec USA Inc | 1 | $13 |
| Sentynl Therapeutics, Inc. | 1 | $12 |
How this compares
$3,102 in reported general payments places this provider in the 85th percentile of 2,067 internal medicine providers in Connecticut.
Other internal medicine in Wallingford
- Devika UmashankerWallingford$91K
- Anace SaidWallingford$53K
- John HuangWallingford$36K
- Steven RyderWestport$3.9M
- Nancy BrownNew Haven$1.6M
- Arthur DecillisMadison$1M
- Charles MontanoCromwell$970K
- Gary BlickNorwalk$683K
- Scott GottliebStamford$508K
- Jeffrey KatzOxford$361K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.